Viewing StudyNCT00226941



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00226941
Status: TERMINATED
Last Update Posted: 2017-12-08
First Post: 2005-09-08

Brief Title: A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin Capecitabine and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Sponsor: George Albert Fisher
Organization: Stanford University

Conditions & Keywords Data

Conditions:
Name
Colo-rectal Cancer
Rectal Cancer
Keywords: